Bridgepoint Development Capital has agreed to acquire a majority stake in Prescient Healthcare from Baird Capital, which has backed the company since 2017 and will re-invest alongside Bridgepoint. Based in London, Prescient Healthcare is a provider of product strategy advisory services for the pharmaceutical and biotech sectors.